Anterior cingulate cortex dysfunction underlies anxiety-like behaviors in MT2-deficient mice

IF 4.6 2区 医学 Q1 NEUROSCIENCES
Xiaodan Wang , Lixia Zhuo , Wei Wu , Dongqi Cui , Huan Sun , Feidi Wang , Peiyu Luo , Yixuan Lyu , Yifang Zhai , Jiao Han , Yan Li , Xin Shen , Ying Xiao , Ruosong Ai
{"title":"Anterior cingulate cortex dysfunction underlies anxiety-like behaviors in MT2-deficient mice","authors":"Xiaodan Wang ,&nbsp;Lixia Zhuo ,&nbsp;Wei Wu ,&nbsp;Dongqi Cui ,&nbsp;Huan Sun ,&nbsp;Feidi Wang ,&nbsp;Peiyu Luo ,&nbsp;Yixuan Lyu ,&nbsp;Yifang Zhai ,&nbsp;Jiao Han ,&nbsp;Yan Li ,&nbsp;Xin Shen ,&nbsp;Ying Xiao ,&nbsp;Ruosong Ai","doi":"10.1016/j.neuropharm.2025.110652","DOIUrl":null,"url":null,"abstract":"<div><div>Anxiety disorders are prevalent mental health conditions with significant impacts on quality of life. While the melatonin type 2 receptor (MT2) has been implicated in anxiety, its specific role and neural mechanisms remain unclear. This study investigates the deficiency of MT2 induces robust anxiety-like phenotypes in mice, mediated through anterior cingulate cortex (ACC) dysfunction. Global knockout (MT2-KO) and conditional ACC-targeted deletion (MT2-cKO) models consistently demonstrated increased anxiety responses in standardized behavioral batteries, establishing ACC MT2 as a key neuromodulator in emotional regulation. Electrophysiological recordings revealed that MT2 deficiency disrupted excitatory-inhibitory (E/I) balance of ACC pyramidal neurons. Chemogenetic activation of MT2-positive neurons in the ACC restored E/I balance and ameliorated anxiety-like behaviors in chronic immobility stress (CIS) model mice. These findings establish MT2 as a pivotal regulator of ACC neurocircuitry and implicate targeted modulation of ACC MT2 signaling as a potential therapeutic strategy for anxiety disorders.</div></div>","PeriodicalId":19139,"journal":{"name":"Neuropharmacology","volume":"279 ","pages":"Article 110652"},"PeriodicalIF":4.6000,"publicationDate":"2025-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuropharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0028390825003600","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0

Abstract

Anxiety disorders are prevalent mental health conditions with significant impacts on quality of life. While the melatonin type 2 receptor (MT2) has been implicated in anxiety, its specific role and neural mechanisms remain unclear. This study investigates the deficiency of MT2 induces robust anxiety-like phenotypes in mice, mediated through anterior cingulate cortex (ACC) dysfunction. Global knockout (MT2-KO) and conditional ACC-targeted deletion (MT2-cKO) models consistently demonstrated increased anxiety responses in standardized behavioral batteries, establishing ACC MT2 as a key neuromodulator in emotional regulation. Electrophysiological recordings revealed that MT2 deficiency disrupted excitatory-inhibitory (E/I) balance of ACC pyramidal neurons. Chemogenetic activation of MT2-positive neurons in the ACC restored E/I balance and ameliorated anxiety-like behaviors in chronic immobility stress (CIS) model mice. These findings establish MT2 as a pivotal regulator of ACC neurocircuitry and implicate targeted modulation of ACC MT2 signaling as a potential therapeutic strategy for anxiety disorders.
前扣带皮层功能障碍是mt2缺陷小鼠焦虑样行为的基础
焦虑症是一种普遍存在的心理健康状况,对生活质量有重大影响。虽然褪黑激素2型受体(MT2)与焦虑有关,但其具体作用和神经机制尚不清楚。本研究探讨了MT2缺乏通过前扣带皮层(ACC)功能障碍介导的小鼠强大的焦虑样表型。全球基因敲除(MT2- ko)和条件ACC靶向缺失(MT2- cko)模型一致显示,在标准化行为电池中,焦虑反应增加,这表明ACC MT2是情绪调节的关键神经调节剂。电生理记录显示,MT2缺乏破坏了ACC锥体神经元的兴奋-抑制(E/I)平衡。慢性不动应激(CIS)模型小鼠ACC中mt2阳性神经元的化学激活恢复了E/I平衡并改善了焦虑样行为。这些发现表明MT2是ACC神经回路的关键调节因子,并暗示ACC MT2信号的靶向调节是焦虑症的潜在治疗策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Neuropharmacology
Neuropharmacology 医学-神经科学
CiteScore
10.00
自引率
4.30%
发文量
288
审稿时长
45 days
期刊介绍: Neuropharmacology publishes high quality, original research and review articles within the discipline of neuroscience, especially articles with a neuropharmacological component. However, papers within any area of neuroscience will be considered. The journal does not usually accept clinical research, although preclinical neuropharmacological studies in humans may be considered. The journal only considers submissions in which the chemical structures and compositions of experimental agents are readily available in the literature or disclosed by the authors in the submitted manuscript. Only in exceptional circumstances will natural products be considered, and then only if the preparation is well defined by scientific means. Neuropharmacology publishes articles of any length (original research and reviews).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信